Valuation: SMAIO

Market Cap 47.88M 54.73M 44.16M 40.79M 77.39M 5.22B 78.69M 528M 207M 2.57B 206M 201M 8.84B P/E 2026 *
-24.7x
P/E 2027 * 121x
Enterprise Value 45.78M 52.33M 42.22M 39M 74M 4.99B 75.24M 504M 198M 2.46B 196M 192M 8.45B EV / Sales 2026 *
3.82x
EV / Sales 2027 * 2.77x
Free-Float
29.17%
Yield 2026 *
-
Yield 2027 * -
1 day-0.93%
1 week+4.17%
Current month+9.54%
1 month+8.97%
3 months+17.40%
6 months+29.77%
Current year+36.00%
1 week 8.28
Extreme 8.28
8.94
1 month 7.44
Extreme 7.44
8.94
Current year 6
Extreme 6
9.1
1 year 5.5
Extreme 5.5
9.1
3 years 2.14
Extreme 2.14
9.1
5 years 1.9
Extreme 1.9
9.1
10 years 1.9
Extreme 1.9
9.1
Manager TitleAgeSince
Chief Executive Officer - 29/12/2008
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2020
Director TitleAgeSince
Chairman - 30/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.93%+4.17%+49.12%+245.53% 54.73M
-2.33%-2.09%+50.33%+162.29% 1,060B
-0.82%-2.30%+62.97%+61.11% 619B
-0.73%-4.98%+27.22%+84.46% 438B
+0.33%-1.17%+27.98%+26.90% 333B
-0.02%-2.85%+25.27%+44.88% 282B
-3.89%-11.22%+20.78%+26.07% 267B
+0.66%-1.42%-29.26%-39.30% 218B
-0.06%-2.88%+20.98%+61.70% 196B
-3.72%-1.10%+13.35%+71.53% 161B
Average -0.90%-2.50%+26.87%+74.52% 357.4B
Weighted average by Cap. -0.56%-2.96%+35.28%+81.27%

Financials

2026 *2027 *
Net sales 11.99M 13.71M 11.06M 10.22M 19.39M 1.31B 19.71M 132M 51.9M 644M 51.48M 50.36M 2.21B 16.76M 19.16M 15.46M 14.28M 27.09M 1.83B 27.54M 185M 72.53M 900M 71.93M 70.37M 3.09B
Net income -1.67M -1.91M -1.54M -1.43M -2.71M -182M -2.75M -18.44M -7.24M -89.89M -7.18M -7.03M -309M 278K 318K 256K 237K 449K 30.31M 457K 3.06M 1.2M 14.93M 1.19M 1.17M 51.34M
Net Debt -2.1M -2.4M -1.94M -1.79M -3.39M -229M -3.45M -23.14M -9.09M -113M -9.01M -8.82M -388M -1.4M -1.6M -1.29M -1.19M -2.26M -153M -2.3M -15.43M -6.06M -75.2M -6.01M -5.88M -259M
Logo SMAIO
S.M.A.I.O « Software, Machines and Adaptive Implants in Orthopaedics » is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, S.M.A.I.O has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs. Net sales break down by source of revenue between sales of products (98.9%) and services (1.1%). Net sales are distributed geographically as follows: France (9.8%), Europe (12.2%), the United States (76.2%), Oceania (1%), Middle East and Africa (0.7%) and Canada (0.1%).
Employees
45
Date Price Change Volume
10/07/26 EUR 8.500 -0.93% 1,388
09/07/26 EUR 8.580 -0.23% 141
08/07/26 EUR 8.600 -1.15% 2,504
07/07/26 EUR 8.700 +0.23% 3,529
06/07/26 EUR 8.680 +6.37% 5,443
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.500EUR
Average target price
8.250EUR
Spread / Average Target
-2.94%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALSMA Stock